Pieter Wyckmans provides expert advice to companies and organizations active in the (bio-) pharmaceutical, biotech and smart devices sectors. Pieter Wyckmans advises multinationals, SMEs, spin-offs and start-ups in (strategic) transactions, intellectual property matters and regulatory affairs.
Pieter Wyckmans combines years of experience as an M&A and commercial transactions lawyer, with years of experience as in-house counsel of multinationals, particularly in the Life Sciences industry.
As in-house counsel, Pieter Wyckmans grew accustomed to the (bio)pharmaceutical and biotech sector and conscious of the scientific, economic and regulatory challenges the industry faces. This understanding, combined with his hands-on approach and pragmatism, is strongly appreciated by his clients. Pieter Wyckmans’ Life Sciences expertise was highlighted in the most recent edition of the Legal 500.
Pieter Wyckmans regularly lectures at seminars and conferences.
Pieter Wyckmans started his career at the corporate M&A department of Linklaters and Loyens&Loeff. He later joined the legal department of BASF and GDF Suez as senior counsel and offered his services as an independent legal consultant to UCB.
Pieter is a member of the Brussels Bar.
